Skip to main content
Asian Pacific Journal of Tropical Biomedicine logoLink to Asian Pacific Journal of Tropical Biomedicine
. 2013 Jul;3(7):523–531. doi: 10.1016/S2221-1691(13)60107-0

Anti-trypanosomal effect of Peristrophe bicalyculata extract on Trypanosoma brucei brucei-infected rats

Abdulazeez Mansurah Abimbola 1, Ibrahim Abdulrazak Baba 1,2,*, Edibo Zakari Yenusa 1, Sidali Joseph Omanibe 1, Idris Habeeb Oladimeji 1
Reviewed by: Emmanuel Balogun DHSc3
PMCID: PMC3695576  PMID: 23835905

Abstract

Objective

To investigate the in vitro and in vivo effect of whole plant extracts of Peristrophe bicalyculata on Trypanosoma brucei brucei-infected rats.

Methods

The experiment was divided into two phases: In the first phase, the anti-trypanosomal activity of the hot water, cold water, methanol and butanol extracts of the whole plant were determined by incubating with Trypanosoma brucei brucei. The cold water extract was partially-purified and the anti-trypanosomal activity of the fractions determined. In the second phase, Trypanosoma brucei brucei-infected rats were treated with fraction 2c for nine days. Packed cell volume (PCV), high density lipoprotein (HDL), low density lipoprotein (LDL), total cholesterol (TC), triacylglycerol (TAG), aspartate aminotransferase, alanine aminotransferases (ALT), alkaline phosphatase (ALP), total and direct bilirubin levels were determined at the end of the experiment.

Results

Cold water extract immobilized 90% of the parasites after 60 min of incubation, and fraction 2c completely immobilized the parasites after 35 min. It significantly increased PCV in Trypanosoma brucei brucei-infected rats. Decreased TC, TAG, HDL and LDL levels of infected rats increased significantly when rats were treated with the fraction, while elevated levels of total bilirubin and ALT also decreased. The difference in urea, direct bilirubin and ALP was not significant when infected rats were compared to rats in other groups.

Conclusions

The ability of the plant to ameliorate the infection-induced biochemical changes calls for detailed investigation of the potentials of the plant for antitrypanosomiasis drug delivery.

Keywords: Anti-trypanosomal activity, Trypanosoma brucei brucei, Peristrophe bicalyculata, Lipoproteins

1. Introduction

African trypanosomiasis is a parasitic disease that affects both humans and animals. It is caused by the protozoan parasite Trypanosoma brucei (T. brucei) which is transmitted by tsetsefly (Glossina genus). Although the number of reported cases in 2009 and 2010 dropped below 10 000, the disease still poses a significant health challenge, especially in sub-saharan Africa (World Health Organization report, 2012). African animal typanosomiasis causes serious losses in Cattle, sheep, goats, pigs, horses and many other host animals[1], thus reducing the source of animal protein[2], and ultimately contributing to food insecurity in the region. The development of a vaccine for the treatment of the disease is becoming increasingly difficult due to the problem of antigenic variation[3], hence the dependence on chemotherapeutic agents to control the disease.

A vast majority of people from less developed countries, including Nigeria depend on medicinal plants for the treatment of various diseases, due to the high cost of synthetic drugs. Most of these plants have proved to be useful sources of treatment of various diseases[4][6]. Indeed, there have been efforts to discover new anti-trypanosomal agents from plants, especially with information obtained from ethnomedical data, whereby a plant is selected based on prior knowledge of its use in folk medicine[7]. However in the case of trypanosomiasis, the use of such data alone may be inadequate, as chemotherapy of trypanosomiasis is presently confronted with problems of unavailability of drugs, resistance to available ones, unacceptability, toxicity and long treatment protocols[8],[9]. Therefore, it is important to search for cheaper, more effective, easily available and less toxic chemotherapeutic agents for the treatment of the disease. Several studies have demonstrated the trypanocidal activity of various plants[7],[10],[11], but there has been no available data on the trypanocidal effect of Perisrophe bicalyculata (P. bicalyculata).

P. bicalyculata is a plant native to warm tropical region of Africa, in the Sahel parts of Mauritania, Niger and Nigeria as well as Burma and Thailand[12]. It has been reported to have anti-inflammatory and anti-bacterial properties[13], antihypertensive[14] and anticancer properties[15]. It is also used in the treatment of skin diseases, and serves as an antidote for snake poison, diabetes among others[16]. The present study was designed to evaluate the anti-trypanosomal activity of different extracts of P. bicalyculata and the possibility of its use as a potential anti-trypanosomal drug candidate. Also, since studies have demonstrated that drugs, whether synthetic or herbal may have significant effect on kidney and liver functions, as well as blood lipid concentration[17][19]; it is pertinent to evaluate these parameters after treatment.

2. Materials and methods

2.1. Plant material

The whole plant of P. bicalyculata were harvested at maturity in the month of August, 2012 at Ibadan (70 26′ N and 3° 54′ E), Oyo State, Nigeria. It was identified and authenticated by the botanist, in the herbarium of the Department of Biological Sciences, Ahmadu Bello University, Zaria, Kaduna State, Nigeria.

The whole plant was air dried in the laboratory and made into powder by grinding. About 50 g was extracted in distilled water (100 mL) by stirring (Harmony Hot Plate Stirrer, Japan) for 30 min to obtain cold water extract. Another 50 g was boiled for 30 min in 100 mL water to obtain hot water extract. The methanol and butanol extracts were obtained by soaking 100 g of extract in 500 mL methanol and butanol respectively, for 48 h. The extracts were sieved using a muslin cloth and then filtered under suction pressure with a Whatman's filter paper. They were then concentrated under reduced pressure using a rotary evaporator (Buchi, Switzerland), lyophilized (Christ Alpha 1-2 LD, Germany) and stored at 40 °C until needed.

2.1.1. Partial purification of cold water extract of P. bicalyculata

The cold water extract was partially purified after thin layer chromatographic separation and fractionated on silica gel packed a column. The column was eluted with acetone (100%), acetone:methanol (15:0.5), acetone:methanol (1:1). Three fractions were obtained (fractions 1, 2a and 2c).

2.2. Parasites

T. brucei brucei was obtained from stabilates maintained at the Nigerian institute for trypanosomiasis research, Kaduna State, Nigeria in the month of July, 2012; and was thereafter maintained in the Department of Parasitology, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, by continuous passage of infected blood into the rats.

2.3. Animals

Thirty six apparently healthy male Wistar rats of approximately 8 weeks old weighing between 200-250 g were purchased from the National Institute of Trypanosomiasis Research, Kaduna State, Nigeria. They were housed under standard laboratory conditions, fed normal rat chow (PLS feeds, Zaria) and given access to clean water ad libitum. They were allowed to acclimatize for a period of 2 weeks before the commencement of the experiment.

The rats were grouped into 6 groups of 6 rats each: Group 1 (Normal; neither infected nor treated), Group 2 (Infected, not treated), Group 3 (Infected, treated with 10 mg/kg diminazene aceturate), Group 4 (Not infected, treated with 200 mg/kg), Group 5 (Infected, treated with 100 mg/kg fraction 2c), Group 6 (Infected, treated with 200 mg/kg fraction 2c).

2.4. Trypanosome infection and treatment

Blood from a highly parasitized mouse was obtained by cardiac puncture, collected into an EDTA-coated sample bottle, and diluted appropriately with physiological saline to serve as inoculum. Rats from groups 2, 3, 5 and 6 were infected intraperitoneally with 0.1 mL of the inoculum containing about 103 trypanosomes/mL. Treatment began a day after the parasites were first detected in the blood stream (day 4) and lasted until the thirteenth day (ie. 9 days of treatment). All experimental protocols were approved and conducted with strict adherence to guidelines of the Institutional Animal Care and Use Committee of Ahmadu Bello University, Zaria, Kaduna State, Nigeria.

2.5. In vitro anti-trypanosomal screening of extracts and fractions of P. bicalyculata

Infected blood obtained from a rat at peak parasitaemia by cardiac puncture was collected in Eppendorf tubes containing 0.2 mL of 1% EDTA prepared with phosphate buffered saline (PBS) and glucose. All extracts were prepared at three concentrations (25, 50 and 100 mg/mL), while 10 mg/mL of diminazeneaceturate was used. Aliquot of 30 µL of the extracts and standard was incubated with 40 µL of the infected blood containing about 32-64 parasites per field[20] in wells of microtitre plates (Flow laboratories Inc., Mclean, Virginia 22101, USA). For the control, phosphate buffer saline (pH 7.4) was used. After 5 min incubation in the wells, about 2 µL of test mixture was placed on microscope slides and the motility of the parasites was observed under the microscope (Olympus CK 40, Japan) at 5 min intervals for 60 min. The procedure was carried out separately for all extracts. A cessation or drop in motility of the parasites in treated blood compared to that of parasite-loaded control blood without extract was taken as a measure of anti-trypanosomal activity, since motility constitutes a relatively reliable indicator of the viability of most zooflagellate parasites[21]. The shorter the time of cessation of motility of the parasite, the more active the extract was considered to be[22].

2.6. Sample collection

Blood was collected at four days interval from the tail of each rat to determine packed cell volume (PCV). At the end of the experiment, rats were sacrificed under anaesthesia to collect blood by cardiac puncture. Blood was allowed to coagulate and serum obtained for biochemical analysis.

2.7. Determination biochemical parameters

PCV was determined by the microhaematocrit method. Low density lipoprotein, high density lipoprotein, triacylglycerol, total cholesterol levels, alanine amino-transferase, aspartate aminotransferase, alkaline phosphatase and bilirubin were determined using assay kits (Randox Laboratories, County Antrim, United Kingdom). Urea and creatinine were determined using Randox kits (Randox Laboratories, County Antrim, United Kingdom).

2.8. Statistical analysis

Data obtained were expressed as mean±standard error of the mean (mean±SEM) and analysed using SPSS 17. Data were subjected to one way analysis of variance and LSD post-hoc test was applied for multiple comparisons. Values of P < 0.05 were regarded as statistically significant.

3. Results

Table 1 shows the yield and percentage yield of extracts using different solvents. The cold water extract yielded 9.03 g, while the hot water extract yielded 7.79 g. The methanol and butanol extracts yielded 18.14 and 10.61 g, respectively.

Table 1. Percentage yield of different extracts of P. bicalyculata.

Extract Yield (g) Percentage (%)
Cold water 9.03 18.06
Hot water 7.79 15.58
Methanol 18.14 18.14
Butanol 10.61 10.61

Result of the in vitro activity of the cold water extract of P. bicalyculata is presented in Figure 1. From the results, the extract at 25 mg/kg did not have effect on the parasites, as all parasites were still motile even after 60 min of incubation. When used at 50 mg/kg, about 50% of parasites were immobilized, while 100 mg/kg of the extract immobilized 90% of the parasites, the response of the cold water extract of P. bicalyculata was dose-dependent. The standard drug, diminazine aceturate completely immobilized the parasites after 20 min incubation.

Figure 1. The in vitro anti-trypanosomal activity of cold extract of Peristrophe bicalyculata at different concentrations.

Figure 1.

The hot water extract of P. bicalyculata at 100 mg/kg immobilized over 70% of the parasites after 40 min of incubation, and the percentage immobilized parasites did not increase even after 60 min, whereas no parasite was motile 25 min after incubation with the standard drug. Sixty min after incubation with the 25 mg/kg extract, all parasites were still motile, while at 50 mg/kg, 50% of the parasites were immobilized, showing a dose-dependent effect (Figure 2).

Figure 2. The in vitro anti-trypanosomal activity of hot water extract of Peristrophe bicalyculata at different concentrations.

Figure 2.

Figure 3 shows the in vitro anti-trypanosomal activity of methanol extract of P. bicalyculata. From the results, the standard drug completely immobilized the parasites after 25 min of incubation, while 20% of the parasites were motile 60 min after incubating with the methanol extract at 100 mg/mL. The extract at 50 mg/mL immobilized 50% of the parasites after 30 min and remained unchanged after 60 min (Figure 3).

Figure 3. The in vitro anti-trypanosomal effect of methanol extract of Peristrophe bicalyculata at different concentrations.

Figure 3.

The butanol extract of P. bicalyculata at 25 and 50 immobilized about 50% of the parasites after 45 and 60 min of incubation. Increasing incubation time to 60 min did not increase the percentage of immobilized parasites treated with the extract at 50 mg/kg. However, at 100 mg/kg, only about 30% of the parasites were motile after 60 min of incubation (Figure 4).

Figure 4. The in vitro anti-trypanosomal effect of butanol extract of Peristrophe bicalyculata at different concentrations.

Figure 4.

Table 2 shows the yield obtained after partially purifying the cold water extract. Fraction 1 was obtained from acetone (100%), fractions 2 and 3 were obtained from acetone:butanol (7:3).

Table 2. Fractions and yields obtained from column chromatographic separation of aqueous extract of P. bicalyculata.

Solvents Fractions Yield (g) Yield (%)
Acetone (100%) Fraction 1 0.56 28.0
Acetone:methanol (7:3) Fraction 2a 0.72 36.0
Acetone:methanol (1:1) Fraction 2c 0.34 17.0
Total yield 1.62 81.0

The effect of the partially-purified fraction (fraction1) of P. bicalyculata is presented in Figure 5. From the results, the effect of the fraction on the mobility of the parasites was dose-dependent. The fraction at 25 mg/kg was inactive, while at 50 mg/kg, over 80% of the parasites were immobilized after 50 min of incubation. However, the 100 mg/kg of the fraction immobilized all the parasites after 50 min of incubation.

Figure 5. The in vitro anti-trypanosomal activity of partially-purified extract of Peristrophe bicalyculata (fraction 1).

Figure 5.

The second fraction obtained after partial purification (fraction 2a), also exhibited a dose-dependent effect (Figure 6). The fraction at 25 and 50 and 100 mg/kg immobilized 50%, 90% and 100% of the parasites after 55, 60 and 45 min, respectively. The standard drug completely immobilized the parasites after 25 min of incubation.

Figure 6. The in vitro anti-trypanosomal activity of partially-purified extract of Peristrophe bicalyculata (fraction 2a).

Figure 6.

From Figure 7, it was observed that the diminazene aceturate completely immobilized the parasites after 25 min of incubation, while, fraction 2c at 100 mg/mL immobilized the parasites after 35 min. At 25 and 50 mg/mL, the fraction immobilized all the parasites after 55 and 60 min of incubation, respectively.

Figure 7. The in vitro anti-trypanosomal activity of partially-purified extract of Peristrophe bicalyculata (fraction 2c).

Figure 7.

Results of PCV of rats treated with the partially-purified fraction of P. bicalyculata is presented on Table 3. There was a significant (P<0.05) decrease in PCV of T. brucei brucei infected rats when compared to normal rats throughout the treatment period. The PCV of infected rats given the partially-purified extract at 100 and 200 mg/kg decreased significantly (P<0.05) by the 8th day (that is 4th day of treatment) when compared with normal rats and rats treated with the standard drug. Although the PCV of normal rats given the extract decreased by 21% after 4 days of treatment, it was significantly (P<0.05) higher than that of infected rats treated with the extract at the same dose (33%). By the 12th day, PCV of infected rats given the extract at 200 mg/kg increased significantly.

Table 3. Effect of the partially purified fraction of P. bicalyculata on packed cell volume of T. brucei brucei-infected rats (n=36).

Groups Day 0 Day 8 Day 12
Normal 39.20±3.13a 40.00±2.10a 43.00±2.14a
Infected untreated 38.40±1.09a 28.00±1.26b 21.70±2.15c
Infected+Standard drug 40.51±1.92a 38.00±1.92a 42.35±2.00a
Normal+Extract (200 mg/mL) 41.20±2.30a 32.56±2.06c 38.78±3.45a,b
Infected+Extract(100 mg/mL) 40.28±3.66a 25.30±2.76b 27.50±3.82b
Infected+Extract(200 mg/mL) 39.42±1.54a 26.67±1.54b 35.43±1.48c

Values with different superscripts within the same column are significantly different at P<0.05.

The levels of total cholestero (TC), triacylglycerol (TAG), high density lipoprotein and low density lipoprotein cholesterol decreased significantly (P<0.05) in T. brucei brucei-infected rats compared to normal rats, but increased significantly (P<0.05) when rats were treated with the standard drug and partially purified extract (Table 4). Normal rats given the partially-purified extract had significantly (P<0.05) lower levels of TC and TAG when compared to untreated normal rats. Also, serum levels of TC, TAG and high density lipoprotein in infected rats treated with the partially-purified extract were significantly (P<0.05) lower than that of normal rats, but higher than infected rats. There was no significant difference in low density lipoprotein levels of normal rats and rats treated with both the standard drug and partially-purified extract (Table 4).

Table 4. Effect of P. bicalyculata on serum lipid profile of T. brucei brucei-infected rats (n=36).

Groups TC (mg/dL) TAG (mg/dL) HDL (mg/dL) LDL (mg/dL)
Normal 235±37.2a 246±69.6a 200±18.1a 205±51.1a
Infected untreated 89±20.9c 110±24.2c 168±15.1c 179±30.2d
Infected+Standard drug 211±37.1ab 222±60.9ab 191±17.6b 196±47.3a
Normal+Extract (200 mg/mL) 203±22.9d 192±22.3ab 203±21.5a 184±28.6a
Infected+Extract(100 mg/mL) 173±28.9b 187±56.7b 177±19.3b 192±39.9a
Infected+Extract(200 mg/mL) 182±25.8b 206±57.1ab 184±16.3ab 195±41.5a

Value with different superscript within the same column are significantly different at P<0.05.

Table 5 shows the effect of partially-purified extract of P. bicalyculata on some parameters of liver function in T. brucei brucei-infected rats. The activity of alanine aminotransferases (ALT) increased significantly (P<0.05) in infected rats compared to normal rats. Administration of standard drug and the partially-purified extract at both 100 and 200 mg/kg reduced it significantly. Infected rats had significantly (P<0.05) lower level of sspartate aminotransferase than normal rats; and administration of the standard drug and the partially-purified extract at 100 and 200 mg/kg did not increase the levels. There was no significant difference in levels of alkaline phosphatase in rats of all groups.

Table 5. Effect of P. bicalyculata on some parameters of liver function in T. brucei brucei-infected rats (n=36).

Groups ALT (U/L) AST (U/L) ALP (U/L)
Normal 0.15 ± 0.04a 0.24 ± 0.03b 0.24 ± 0.03a
Infected untreated 0.23 ± 0.02b 0.19 ± 0.01ab 0.29 ± 0.03a
Infected+Standard drug 0.13 ± 0.01a 0.20 ± 0.01ab 0.24 ± 0.03a
Normal+Extract (200 mg/mL) 0.14 ± 0.02a 0.26 ± 0.02b 0.25 ± 0.03a
Infected+Extract(100 mg/mL) 0.12 ± 0.01a 0.18 ± 0.02ab 0.28 ± 0.02a
Infected+Extract(200 mg/mL) 0.12 ± 0.01a 0.15 ± 0.02a 0.28 ± 0.02a

Values with different superscripts within the same column are significantly different at P<0.05.

The level of total bilirubin increased significantly (P<0.05) in T. brucei brucei infected rats compared to normal rats and all treated rats (Table 6). There was no significant difference in total bilirubin levels between normal and infected rats treated with the extract, infected rats treated with the standard drug and normal rats. However there was no significant (P>0.05) difference in the levels of direct bilirubin in rats of all groups.

Table 6. Effect of P. bicalyculata on bilirubin levels in T. brucei brucei-infected rats.

Groups Total bilirubin (U/L) Direct bilirubin (U/L)
Normal 0.10 ± 0.04ab 0.07 ± 0.01a
Infected untreated 0.18 ± 0.04b 0.11 ± 0.01a
Infected+Standard drug 0.08 ± 0.03ab 0.09 ± 0.01a
Normal+Extract (200 mg/mL) 0.09 ± 0.03ab 0.12 ± 0.03a
Infected+Extract(100 mg/mL) 0.07 ± 0.02ab 0.09 ± 0.02a
Infected+Extract(200 mg/mL) 0.08 ± 0.02ab 0.10 ± 0.01a

RValues with different superscripts within the same column are significantly different at P<0.05.

There was a significant (P<0.05) increase in serum creatinine levels of T. brucei brucei infected rats when compared to normal rats and normal rats treated with the partially-purified extract (Table 7). This decreased significantly (P<0.05) after administration of standard drug, but the partially purified extract at both 100 and 200 mg/kg, did decrease creatinine levels when compared to normal rats. The levels of urea were not significantly different in rats of all groups.

Table 7. Effect of P. bicalyculata on kidney function in T. brucei brucei-infected rats.

Groups Urea (mg/dL) Creatinine (mg/dL)
Normal 0.68 ± 0.07a 0.22 ± 0.03a
Infected untreated 0.64 ± 0.09a 0.31± 0.03ab
Infected+Standard drug 0.67 ± 0.10a 0.24 ± 0.03a
Normal+Extract (200 mg/mL) 0.65 ± 0.08a 0.22 ± 0.09a
Infected+Extract(100 mg/mL) 0.66 ± 0.10a 0.28 ± 0.02ab
Infected+Extract(200 mg/mL) 0.66 ± 0.10a 0.28 ± 0.02ab

Value with different superscripts within the same column are significantly different at P<0.05.

4. Discussion

Parasites motility constitute a relatively reliable indicator of viability of most zoo flagellate parasites and an arrest or drop in motility of trypanosomes may serve as a measure of anti-trypanosomal activity of plant extracts when compared to the control, phosphate-glucose buffer saline[23]. Similarly, it has been reported that a complete elimination or reduction of motility of parasites when compared to the control could be taken as index of trypanocidal activity[21]. From the results in the present study, all crude extracts of P. bicalyculata: cold water, hot water, butanol and methanol extracts exhibited in vitro anti-trypanosomal activity against T. brucei brucei, however, the cold water extract was considered most active as it inhibited the 90% of the parasites after 60 min of incubation compared to other extracts. Partial purification of this extract yielded three fractions (1, 2a and 2c), with fraction 2c being most active as it completely immobilized the parasites within the shortest time (35 min) when compared with other extracts.

Studies have shown that there are times when plants with in vitro anti-trypanosomal activity may have no effect in vivo, probably due to peculiarities in the metabolic disposition of the chemical constituents within the plant[11], thus, the in vivo effect of the fraction was determined to ascertain its anti-trypanosomal activity.

Anaemia is a constant feature of trypanosome infections whose severity is linked to the level of parasitaemia[24], a measurement of anaemia provides information on the severity of a disease. The significant decrease in PCV of T. brucei brucei infected rats is in consonance with earlier reports[4],[25]in trypanosome-infected animals. This has been attributed to the release of hemolytic factors into the animals blood by dead trypanosomes causing destruction of erythrocytes and hence, reduction in PCV[22],[26]. It has also been reported that anaemia may be caused by erythrocyte injury caused by lashing action of trypanosome flagella, undulating pyrexia, platelet aggregation, toxins and metabolites from trypanosomes, lipid peroxidation and malnutrition[27]. The increase in PCV after treatment with fraction 2c at 100 and 200 mg/kg may be due to its ability to eliminate parasites from the blood, probably by reaching the site of action or rapid metabolization[4],[28]. Also, the antioxidant activity of the plant[13] may have contributed to the increase, as studies have demonstrated the ability of vitamins to ameliorate anaemia in trypanosome-infected rats[29],[30].

Reports have shown that lipids play important roles in the pathogenesis of trypanosomiasis[31],[32]. From the findings in this study, it is reasonable to infer that T. brucei infection causes significant decrease in the serum levels of cholesterol, high density lipoprotein, triacylglycerol and low density lipoprotein. The findings in this study are in conformity with other reports[33][36]. Although we cannot ascertain the reasons for the sudden drop, some pathophysiological mechanisms may be involved. It has been reported that lipids serve as an important source of energy for T. brucei[31],[32], thus, the lowering of the serum lipids and cholesterol as observed in the present study could, partly, be the result of trypanosomal utilization of the molecules. Thus, the continuous utilization of these molecules from the blood stream could be a contributory factor to lowering of the serum levels of lipids and cholesterol. Also, it is known that blood-stream trypanosomes scavenge blood glucose for energy[31], which could cause hypoglycemia in the trypanosome-infected animal. Although blood glucose level was not determined in this study, hypoglycemia can undoubtedly result in increased catabolism of lipids and cholesterol in order to meet some strategic energy needs in the body of the host animal[31],[32]. Consequently, this could lead to decrease in serum levels of these molecules as observed in the present study. Also, studies have demonstrated that low feed intake associated with trypanosomiasis[34] may affect blood levels of the triglyceride, high density lipoprotein and cholesterol in infected animals.

In this study, serum ALT levels increased, while there was no difference in levels of alkaline phosphatase in infected rats when compared to normal rats. This agrees with studies where ALT was elevated in Trypanosomaevansi-infected[37] and T. brucei brucei-infected[38] animals. Several other studies have reported elevated serum enzymes[29],[39],[40]. The elevation of these enzymes is usually indicative of liver damage, being the major liver maker enzymes; or partly to cellular damage caused by lysis or destruction of the trypanosomes[38].

The high levels of total bilirubin in infected rats in this experiment supports earlier observations in several trypanosome-infected animals[41][43]. The increase in bilirubin is suggestive of haemolytic anaemia which may be due to the activity of proliferating parasites. It could also be associated to the inability of the liver to conjugate bilirubin[42]. The liver detoxifies harmful substances secretes bile into the intestine synthesizes and stores up important material, hence, it is common in clinical practice to screen for liver disease, monitor the progression of a known disease and monitor the effect of potentially hepatotoxic drugs[44]. Administration of the standard drug, diminazine aceturate and the partially-purified fraction of P. bicalyculata prevented, to a significant extent, the disease-induced increases in serum ALT. This suggests that the fraction protected the liver against some oxidative species generated during the disease, probably by virtue of its antioxidant property, providing greater protection to plasma membrane and other susceptible cellular structures against oxidative agents[29],[30].

The elevated creatinine level in the T. brucei-infected rats agrees with previous findings[39],[43] and could be due to destruction of kidney cells resulting in the inability of the kidneys to excrete creatinine[43]. The decrease in creatinine levels when rats were given fraction 2c indicated that the ability of the fraction to provide some degree of protection to the kidneys during the course of the disease[11].

In conclusion, this study has established the in vitro and in vivo anti-trypanosomal activity of P. bicalyculata, and its potential as a possible drug candidate in the management of trypanosomiasis. Although the exact mechanism of action is unknown, previous reports have attributed the trypanocidal activity of a number of tropical plants to their flavonoids, alkaloids and other phytochemicals constituents[45][47]. Also, it has been suggested that many natural products exhibit their trypanocidal effect by interfering with the redox balance of the parasites acting either on the respiratory chain or on the cellular defenses against oxidative stress[11]. Thus, the anti-trypanosomal activity of P. bicalyculata may be attributed to its high antioxidant activity and its phenol, flavonoids and alkaloid contents[13].

Acknowledgments

The authors wish to express their gratitude to Mr. Nwosu and other Laboratory staff members of the Department of Physiology and Pharmacology, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Kaduna State, Nigeria. The research was funded by Education Trust Fund of Nigeria with the grant number ETF/DESS/AS&D/UNIV/ABU/ZARIA/V2.

Comments

Background

The chemotherapy of African trypanosomiasis is besieged with numerous problems as most trypanocides are toxic, require lengthy parenteral administration, lack efficacy and are unaffordable. Also, a suitable vaccine is yet to be developed. Thus, there is a need for alternatives that are safe, effective and affordable. Emphasis is now shifting to medicinal plants and other natural products in search of such molecules that could be further developed into new antitrypanosomal agents

Research frontiers

This study was done to investigate the in vitro and in vivo effect of whole plant extracts of P. bicalyculata on T. brucei brucei. A lot of research is being undertaken in this field as a result of the persistent problem of Trypanosomiasis.

Related reports

The result of this study agrees with Faremi and Ekanem (2011), Wurochekke and Anyanwu (2012) demonstrating that plants with antitrypanosomal activity result in increased PCV. Also, the present study agrees with Biryomumaisho et al (2003), Adamu et al (2008) and Taiwo et al (2003) that T. brucei infection causes significant decrease in serum lipoprotein levels, which increased on treatment with antitrypanosomal plants.

Innovations and breakthroughs

P. bicalyculata, the plant used in this study has been shown to possess many medicinal properties, however, there has been no research done to determine its antitrypanosomal activity. Results from the current study has demonstrated the antitrypanosomal activity of the cold water extract of the plant. Also, partial purification of the extract yielded a very active fraction.

Applications

This study has established the in vitro and in vivo anti-trypanosomal activity of P. bicalyculata, and its potential as a possible drug candidate in the management of trypanosomiasis.

Peer review

The study has gone a step further in the search of anti-trypanosomiasis drug candidate. The potential of using the plant has also been established, making it a ground-breaking research for more works to be done to further ascertain the use of the plant for trypanosomiasis treatment.

Footnotes

Foundation Project: Supported by Education Trust Fund of Nigeria with the grant number ETF/DESS/AS&D/UNIV/ABU/ZARIA/V2.

Conflict of interest statement: We declare that we have no conflict of interest.

References

  • 1.Denbarga Y, Ando O, Abebe R. Trypanosoma species causing bovine trypanosomosis in South Achefer District, Northern Ethiopia. J Vet Adv. 2012;2(2):108–113. [Google Scholar]
  • 2.Guilherme M, Andre T. Nutritional status driving infection by Trypanosoma cruzi: Lessons from experimental animals. J Trop Med. 2011;2011:981879. doi: 10.1155/2011/981879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Jackson AP, Berry A, Aslett M, Allison HC, Burton P, Anderson AV, et al. et al. Antigenic diversity is generated by distinct evolutionary mechanisms in African trypanosome species. Proc Natl Acad Sci USA. 2012;109(9):3416–3421. doi: 10.1073/pnas.1117313109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Oduola T, Bello I, Adeosun G, Ademosun A, Raheem G, Avwioro G. Hepatotoxicity and nephrotoxicity evaluation in Wistar albino rats exposed to Morinda lucida leaf extract. N Am J Med Sci. 2010;2(5):230–233. doi: 10.4297/najms.2010.2230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Devaki K, Beulah U, Akila G, Gopalakrishnan VK. Effect of aqueous extract of Passiflora edulis on biochemical and hematological parameters of Wistar albino rats. Toxicol Int. 2012;19(1):63–67. doi: 10.4103/0971-6580.94508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lawal HO, Etatuvie SO, Fawehinmi AB. Ethnomedicinal and pharmacological properties of Morinda lucida. J Natural Products. 2012;5:93–99. [Google Scholar]
  • 7.Wurochekke AU, Anyanwu GO. Antitrypanosomal activity of Anogeissus leiocarpus in rats infected with Trypanosoma brucei brucei. Int Res J Biotechnol. 2012;3(1):5–9. [Google Scholar]
  • 8.Toya NB. Immunobiology of African trypanosomes: Need of alternative interventions. J Biomed Biotechnol. 2010 doi: 10.1155/2010/389153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Barrett MP, Vincent IM, Burchmore RJ, Kazibwe AJ, Matovu E. Drug resistance in human African trypanosomiasis. Future Microbiol. 2011;6(9):1037–1047. doi: 10.2217/fmb.11.88. [DOI] [PubMed] [Google Scholar]
  • 10.Antia RE, Olayemi JO, Aina OO, Ajaiyeoba EO. In vitro and in vivo animal model antitrypanosomal evaluation of ten medicinal plant extracts from southwest Nigeria. Afr J Biotechnol. 2009;8(7):1437–1440. [Google Scholar]
  • 11.Umar AI, Ibrahim T, Akombum CA, Nnadi CJ, Mahdi MA, Gidado A. et al. The role of intraperitoneally administered vitamin C during Trypanosoma congolense infection of rabbits. Afr J Biotech. 2010;9(32):5224–5228. [Google Scholar]
  • 12.Burkill HM. The useful plants of west tropical Africa. 2nd Edition. United Kingdom: Royal Botanic Gardens; 1985. [Google Scholar]
  • 13.Janakiraman N, Sahaya SS, Johnson M. Anti-bacterial studies on Peristrophe bicalyculata (Retz.) Nees. Asian Pac J Trop Biomed. 2012;1:2. [Google Scholar]
  • 14.Abdulazeez AM, Awasum CA, Dogo YS, Abiayi PN. Effect of Peristrophe bicalyculata on the blood pressure and kidney and liver functions of two kidney-1-clip hypertensive rats. Br J Pharmacol Toxicol. 2011;1(2):101–107. [Google Scholar]
  • 15.Tanavade SS, Naikwade NS, Chougule DD. In vitro anticancer activity of ethanolic extracts of Peristrophe bicaliculata Nees. Int J Chem Sci. 2012;10(1):317–323. [Google Scholar]
  • 16.Chopra H. Medicinal herbs of Chhattisgarh, India having less known traditional uses. 1959 [Online] Availavle from: http://www.botanical.com/. [Google Scholar]
  • 17.Elvin-Lewis M. Should we be concerned about herbal remedies. J Ethnopharm. 2001;75(2–3):141–164. doi: 10.1016/s0378-8741(00)00394-9. [DOI] [PubMed] [Google Scholar]
  • 18.Oyedemi SO, Bradley G, Afolayan AJ. Toxicological effects of the aqueous stem bark extract of Strychnos henningsii Gilg in Wistar rats. J Nat Pharm. 2010;1:33–39. [Google Scholar]
  • 19.Ashafa OT, Orekoya LO, Yakubu MT. Toxicity profile of ethanolic extract of Azadirachta indica stem bark in male Wistar rats. Asian Pac J Trop Biomed. 2012;2(10):811–817. doi: 10.1016/S2221-1691(12)60234-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Herbert WJ, Lumsden WHR. Trypanosoma brucei: A rapid matching method for estimating the host's parasitaemia. Exp Parasitol. 1976;40:427–431. doi: 10.1016/0014-4894(76)90110-7. [DOI] [PubMed] [Google Scholar]
  • 21.Atawodi SE, Ogunbusola F. Evaluation of anti-trypanosomal properties of four extracts of leaves, stem and root barks of Prosopis africana in laboratory animals. Biokemistri. 2009;21(2):101–108. [Google Scholar]
  • 22.Atawodi SE, Bulus T, Mamman M. Bioassay guided fractionation and anti-trypanosomal effect of fractions and crude aqueous and methanolic extracts of Terminalia avicennioides (Guill. & Perr.) parts. Int J Biol. 2011;3(3):19–30. [Google Scholar]
  • 23.Kaminsky R, Brun R. In vitro assays to determine drug sensitivities of African trypanosomes: a review. Acta Trop. 1993;54:279–289. doi: 10.1016/0001-706x(93)90100-p. [DOI] [PubMed] [Google Scholar]
  • 24.Coustou V, Plazolles N, Guegan F, Baltz T. Sialidases play a key role in infection and anaemia in Trypanosoma congolense animal trypanosomiasis. Cell Microbiol. 2012;14(3):431–445. doi: 10.1111/j.1462-5822.2011.01730.x. [DOI] [PubMed] [Google Scholar]
  • 25.Faremi AY, Ekanem JT. Haematological parameters and enzyme studies in Trypanosoma brucei-infected rats reared on Nigella sativa oil-based diet. Asian J Biochem. 2011;6:90–97. [Google Scholar]
  • 26.Olukunle JO, Abatan MO, Soniran OT, Takeet MI, Idowu OA, Akande FA, et al. et al. In vivo antitrypanosomal evaluation of some medicinal plant extracts from Ogun State, Nigeria. Sci World J. 2010;5(10):17–19. [Google Scholar]
  • 27.Mbaya A, Kumshe H, Nwosu CO. The mechanisms of anaemia in trypanosomosis: A review. In: Silverberg S, editor. Anemia. Croatia: InTech; 2012. pp. 269–282. [Google Scholar]
  • 28.Wurochekke AU, James DB, Bello MI, Ahmodu A. Trypanocidal activity of the leaf of Guira senegalensis against Trypanosoma brucei brucei infection in rats. J Med Sci. 2005;5:1–4. [Google Scholar]
  • 29.Umar IA, Ogenyi E, Okodaso D. Amelioration of anemia and organ damage by combined intraperitoneal administration of vitamin A and C to Trypanosoma brucei brucei infected rat. Afr J Biotech. 2007;6:2083–2086. [Google Scholar]
  • 30.Eghianruwa KI. The effect of supplemental antioxidants vitamin C and dimethylsulfoxide on weight gain and survival in T. brucei infected and diminazene treated rats. Veterinarski Arhiv. 2012;82(5):519–529. [Google Scholar]
  • 31.Van Hellemond JJ, Tielens AGM. Adaptations in the lipid metabolism of the protozoan parasite Trypanosoma brucei. FEBS Lett. 2006;580:5552–5558. doi: 10.1016/j.febslet.2006.07.056. [DOI] [PubMed] [Google Scholar]
  • 32.Vigueira PA, Ray SSb, Martin BA, Ligon MM, Paul KS. Effects of the green tea catechin (-)-epigallocatechin gallate on Trypanosoma brucei. Int J Parasitol Drugs Drug Resistance. 2012;2:225–229. doi: 10.1016/j.ijpddr.2012.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bala AY, Adamu T, Abubakar U, Ladan MJ. Inhibition of Trypanosoma brucei brucei by extracts from Waltheria indica L. (sleepy morning) Res J Parasitol. 2011;6:53–59. [Google Scholar]
  • 34.Adamu S, Ige AA, Jatau ID, Neils JS, Useh NM, Bisalla M, et al. Changes in the serum profiles of lipids and cholesterol in sheep experimental model of acute African trypanosomosis. Afr J Biotechnol. 2008;7(12):2090–2098. [Google Scholar]
  • 35.Bala AY, Adamu T, Abubakar U, Ladan MJ. Amelioration of trypanosome-infection-induced alterations in serum cholesterol, triglycerides and proteins by hydro-ethanolic Extract of Waltheria indica in Rats. Res J Parasitol. 2012;6:127–135. [Google Scholar]
  • 36.Adam S, Barde N, Abenga JN, Useh NM, Ibrahim NDG, Esievo KAN. Experimental Trypanosoma brucei infection-induced changes in the serum profiles of lipids and cholesterol and the clinical implications in pigs. J Cell Anim Biol. 2009;3(2):15–20. [Google Scholar]
  • 37.Sazmand A, Aria R, Mohammad N, Hosein H, Seyedhossein H. Serobiochemical alterations in subclinically affected dromedary camels with Trypanosoma evansi in Iran. Pak Vet J. 2011;31(3):223–226. [Google Scholar]
  • 38.Yusuf AB, Umar IA, Nok AJ. Effects of methanol extract of Vernonia amygdalina leaf on survival and some biochemical parameters in acute Trypanosoma brucei brucei infection. Afr J Biochem Res. 2012;6(12):150–158. [Google Scholar]
  • 39.Allam L, Ogwu D, Agbede RIS, Sackey AKB. Hematological and serum biochemical changes in gilts experimentally infected with Trypanosoma brucei. Veterinarski Arhiv. 2011;81(5):597–609. [Google Scholar]
  • 40.Abd El-Baky AA, Salem SI. Clinicopathological and cytological studies on naturally infected camels and experimentally infected rats with Trypanosoma evansi. World Appl Sci J. 2011;14(1):42–50. [Google Scholar]
  • 41.Boniface A, Augustine I, Ikechukwu I, Paschal U. Prevalence and haemato-biochemical parameters of trypanosome-infected pigs at Nsukka, Nigeria. Comparative Clin Pathol. 2011;20(1):15–18. [Google Scholar]
  • 42.Adeyemi OS, Akanji MA, Ekanem JT. Ethanolic extract of Psidium guajava influences protein and bilirubin levels in Trypanosoma brucei brucei infected rats. J Biol Sci. 2012;12(2):111–116. [Google Scholar]
  • 43.Ezeokonkwo RC, Ezeh IO, Onunkwo JI, Onyenwe IW, Iheagwam CN, Agu WE. Comparative serum biochemical changes in mongrel dogs following single and mixed infections of Trypanosoma congolense and Trypanosoma brucei brucei. Vet Parasitol. 2012;190(1–2):56–61. doi: 10.1016/j.vetpar.2012.05.012. [DOI] [PubMed] [Google Scholar]
  • 44.Kapoor S. Hepascore: A new liver function test. J Clin Diagnostic Res. 2011;5(1):155–156. [Google Scholar]
  • 45.Nok AJ. Azaanthraquinone inhibits respiration and in vitro growth of long slender blood stream forms of T. congolense. Cell Biochem Func. 2001;20:205–212. doi: 10.1002/cbf.948. [DOI] [PubMed] [Google Scholar]
  • 46.Mann A, Barnabas BB, Daniel II. The effect of methanolic extracts of Anogeissus leiocarpus and Terminalia avicennioides on the growth of some food-borne microorganisms. Aust J Basic Appl Sci. 2010;4(12):6041–6045. [Google Scholar]
  • 47.Kaboré A, Tamboura HH, Traoré A, Traoré A, Meda R, Kiendrebeogo M, et al. et al. Phytochemical analysis and acute toxicity of two medicinal plants (Anogeissus leiocarpus and Daniellia oliveri) used in traditional veterinary medicine in Burkina Faso. Arch Appl Sci Res. 2010;2(6):47–52. [Google Scholar]

Articles from Asian Pacific Journal of Tropical Biomedicine are provided here courtesy of China Humanity Technology Publishing House

RESOURCES